|
|
 Previous Article | Table of Contents | Next Article 
High Rates of Hepatitis G Virus Infection in Multitransfused Patients With Hemophilia
Francesca De Filippi,
M. Colombo,
Maria Grazia Rumi,
F. Tradati,
D. Prati,
A. Zanella, and
P.M. Mannucci
From the "Angela Maria e Antonio Migliavacca" Center for Liver Disease and Liver Cancer Unit Fondazione Italiana Ricerca Cancro/University of Milan; the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, University of Milan; and the Blood Transfusion and Transplant Immunology Center, Istituto Ricovero Cura Caratiere Scientifico Maggiore Hospital, Milan, Italy.
The parallel measurement of serum antibodies to the hepatitis G virus (anti-HGV) and of viremia (HGV-RNA) should improve our understanding of HGV transmission by coagulation factor concentrates. The aim of this study was to assess the relationship between HGV, the type of concentrate infused, and liver disease in multitransfused hemophiliacs. To this end, anti-HGV and HGV-RNA were evaluated by an enzyme-linked immunosorbent assay and a nested-polymerase chain reaction assay in patients treated lifelong with nonvirus-inactivated plasma-derived concentrates (n = 128), virus-inactivated concentrates (n = 33), or recombinant factors (n = 7), and in 200 regular blood donors. The prevalence of serum HGV-RNA and anti-HGV was higher in the recipients of nonvirus-inactivated factors than in blood donors (HGV-RNA: 9% v 1.5%, P = .002; anti-HGV: 32% v 5%, P < .0001). In the recipients of virus-inactivated concentrates the prevalences of these markers were similar to those in blood donors (HGV-RNA: 3% v 1.5%; anti-HGV: 15% v 5%). The prevalence of either marker in the recipients of nonvirus-inactivated concentrates was higher than in the recipients of virus-inactivated factors (39% v 18%, P = .04). The former group had serum hepatitis C virus (HCV) RNA or anti-HCV more frequently than the latter group (HCV-RNA: 86% v 15%, P < .0001; anti-HCV: 96% v 18%, P < .0001). Serum alanine aminotransferase was persistently high in 83 (81%) patients with HCV-RNA alone, in 8 (89%) with HCV/HGV coinfection, and in none of the three patients with HGV-RNA only. Thus, HGV infection in hemophiliacs is more common than previous studies of HGV-RNA prevalence have suggested, but it resolved in most cases and caused chronic viremia only in a small number of patients, without biochemical evidence of persistent liver damage.
Blood, Vol. 90 No. 11 (December 1), 1997:
pp. 4634-4637
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
B. P. Chen, M. G. Rumi, M. Colombo, Y.-H. Lin, L. Ramaswamy, J. Luna, J.-K. Liu, D. Prati, and P. M. Mannucci
TT Virus Is Present in a High Frequency of Italian Hemophilic Patients Transfused With Plasma-Derived Clotting Factor Concentrates
Blood,
December 15, 1999;
94(12):
4333 - 4336.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Woelfle, T. Berg, R. Bialek, K. M. Keller, W. Effenberger, and N. Wagner
GB virus C/hepatitis G virus infection in HIV infected patients with haemophilia despite treatment with virus inactivated clotting factor concentrates
Arch. Dis. Child.,
May 1, 1999;
80(5):
429 - 432.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. Prati, Y.-H. Lin, C. De Mattei, J.-K. Liu, E. Farma, L. Ramaswamy, A. Zanella, H. Lee, P. Rebulla, J.-P. Allain, et al.
A Prospective Study on TT Virus Infection in Transfusion-Dependent Patients With beta -Thalassemia
Blood,
March 1, 1999;
93(5):
1502 - 1505.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Prati, A. Zanella, E. Farma, C. De Mattei, P. Bosoni, M. Zappa, A. Picone, F. Mozzi, P. Rebulla, M. D. Cappellini, et al.
A Multicenter Prospective Study on the Risk of Acquiring Liver Disease in Anti-Hepatitis C Virus Negative Patients Affected From Homozygous beta -Thalassemia
Blood,
November 1, 1998;
92(9):
3460 - 3464.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. P. Mauser-Bunschoten, M. Damen, H. L. Zaaijer, M. Sjerps, G. Roosendaal, P. N. Lelie, H. T. M. Cuypers, and H. M. van den Berg
Hepatitis G Virus RNA and Hepatitis G Virus-E2 Antibodies in Dutch Hemophilia Patients in Relation to Transfusion History
Blood,
September 15, 1998;
92(6):
2164 - 2168.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
